Contact: Lisa Merkl
University of Houston
Caption: A team led by Dr. Jan-Åke Gustafsson at the University of Houston has demonstrated that the nuclear receptor liver X receptor beta shows promise as a potential therapeutic target for Parkinson's disease, as well as other neurological disorders.
Credit: Thomas Campbell
Usage Restrictions: None
Related news release: Therapeutic avenues for Parkinson's investigated at UH